Redmile Biopharma Investments III LP

-

Fund Information and Directors

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Redmile Biopharma Investments III LP
Firm Redmile Group LLC
Fund #805-5445849187
CIK #0001838746
Sale2020-12-23 (500.2 M Sold)
FundPrivate Equity Fund
Phone4154899980
AddressLetterman Digital Arts Center
San Francisco, California 94129
Source [EDGAR] [IAPD]
Fund AUM and Sold ($M)
120096072048024002010201520212027
Fund Details
DirectorRedmile Biopharma Investments III GP LLC, Redmile Biopharma Investments III GP LLC - General Partner
CustodianFirst Republic Bank, JP Morgan Chase Bank NA, Morgan Stanley & Co LLC
AuditorErnst & Young LLP
MarketerHoulihan Lokey Capital Inc, Morgan Stanley, JP Morgan Securities LLC
BrokerMorgan Stanley & Co LLC
Jurisdiction
Form D Offering
Filed2021-01-04 (D)
Exemption506(b), 3(c), 3(c)(7)
Minimum$100,000
RemainingIndefinite
DurationMore than one year
RevenueDecline to Disclose
Investors330
DirectorsRole2011 - 2026
Redmile Biopharma Investments III GP LLC Promoter
Jeremy Green Executive Officer
Mike Lee Executive Officer
Redmile Group LLC Executive Officer
Amrit Nagpal Executive Officer
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com